Today: 8 February 2026
Subscribe
Browse Category

Earnings Reports News 28 January 2026

GSK share price slips in London as Arexvy EU expansion sinks in; earnings next week in focus

GSK share price slips in London as Arexvy EU expansion sinks in; earnings next week in focus

GSK shares dropped 1.8% to 1,828.5 pence by mid-morning Wednesday in London, reversing gains from earlier in the week. The decline followed news that the European Commission expanded approval of GSK’s RSV vaccine Arexvy to all adults 18 and older. Pfizer also secured similar approval for its RSV shot. Investors await guidance from European health agencies and GSK’s earnings report on February 4.
28 January 2026
···
Unilever share price slips in early London trade as investors line up February results

Unilever share price slips in early London trade as investors line up February results

Unilever shares slipped 0.7% to 4,831.5 pence in early London trading, underperforming the FTSE 100’s 0.1% drop. Investors await Unilever’s full-year results on Feb. 12, focusing on volume growth and margins after the company spun off its Magnum unit and consolidated shares. European stocks paused after a two-day rally, with attention shifting to the U.S. Fed decision later today.
28 January 2026
··
Yangzijiang Shipbuilding stock edges up to S$3.33 as Singapore STI dips — traders eye Fed, March earnings

Yangzijiang Shipbuilding stock edges up to S$3.33 as Singapore STI dips — traders eye Fed, March earnings

Yangzijiang Shipbuilding shares rose 0.3% to S$3.33 in afternoon trading Wednesday, rebounding after a late-January dip but still 11% below their Jan. 14 high. Short selling made up 43% of Tuesday’s 20.3 million shares traded. Singapore’s Straits Times Index slipped 0.47% after a 1.28% gain Tuesday. Yangzijiang’s next earnings release is scheduled for March 4.
28 January 2026
··
Woodside Energy share price jumps after Q4 report, but 2026 output dip keeps traders cautious

Woodside Energy share price jumps after Q4 report, but 2026 output dip keeps traders cautious

Woodside Energy shares rose 2.7% to A$24.98 after its fourth-quarter update, despite forecasting lower 2026 output due to scheduled downtime at Pluto LNG. December-quarter revenue fell to $3.035 billion from $3.484 billion a year earlier. Scarborough project is 94% complete, with first LNG cargo expected in late 2026. Investors await the annual report briefing on Feb. 24.
28 January 2026
···
Why Gilead stock hit a fresh 52-week high as Medicare targets Biktarvy and earnings loom

Why Gilead stock hit a fresh 52-week high as Medicare targets Biktarvy and earnings loom

Gilead Sciences shares rose 2.3% to $140.97 Tuesday, hitting a 52-week high after Medicare named its HIV drug Biktarvy for price negotiations starting in 2028. Trading volume topped 10.5 million shares. CEO Daniel O’Day sold 115,640 shares last week under a pre-set plan. Gilead will report fourth-quarter and full-year results after markets close on Feb. 10.
28 January 2026
···
HCA stock jumps after earnings and a $10B buyback — what to watch before Wednesday’s open

HCA stock jumps after earnings and a $10B buyback — what to watch before Wednesday’s open

HCA Healthcare shares surged 7.1% to $505.84 after the company raised its 2026 profit outlook and approved a new $10 billion share buyback. Fourth-quarter revenue rose 6.7% to $19.51 billion, with net income at $1.88 billion. Investors remain cautious as ACA exchange subsidies expire, potentially reducing patient volumes. The board also declared a $0.78 quarterly dividend, payable March 31.
28 January 2026
··
Starbucks stock dips as supply-chain snags and CEO jet policy land ahead of earnings

Starbucks stock dips as supply-chain snags and CEO jet policy land ahead of earnings

Starbucks shares fell 0.6% to $95.72 Tuesday ahead of its fiscal first-quarter earnings report set for Wednesday morning. CEO Brian Niccol is under scrutiny as supply-chain issues persist despite new technology and system upgrades. The company also removed the $250,000 cap on Niccol’s personal use of the corporate jet after a security review. Wall Street analysts adjusted price targets as investors focus on sales and margins.
28 January 2026
··
Elevance Health stock gets hit by Medicare rate surprise — what traders watch before earnings

Elevance Health stock gets hit by Medicare rate surprise — what traders watch before earnings

Elevance Health shares fell 14.3% to $322.92 Tuesday after a Medicare Advantage rate proposal from CMS projected a net average payment increase of just 0.09%, far below Wall Street expectations. The move triggered a broader selloff in health insurer stocks. Investors are awaiting Elevance’s earnings report Wednesday for updates on pricing and costs. CMS will finalize policy milestones in late February and early April.
28 January 2026
··
KLA stock jumps nearly 5% as analysts lift targets ahead of Jan. 29 earnings

KLA stock jumps nearly 5% as analysts lift targets ahead of Jan. 29 earnings

KLA shares rose 4.8% to about $1,616 in after-hours trading Tuesday after Evercore ISI and Wolfe Research raised price targets ahead of Thursday’s earnings. The company projects fiscal Q2 revenue of $3.225 billion and non-GAAP EPS of $8.70, with Zacks’ consensus slightly higher. KLA warned U.S.-China trade tensions could cut sales by up to $350 million over the next five quarters.
28 January 2026
··
Mastercard stock price slips after Agent Suite AI launch as earnings near

Mastercard stock price slips after Agent Suite AI launch as earnings near

Mastercard shares fell 1.3% to $520.41 Tuesday, underperforming the S&P 500, as investors awaited Thursday’s earnings report. The company launched “Mastercard Agent Suite,” a set of AI-powered business tools, set for release in the second quarter. Trading volume was above average. Cantor Fitzgerald began coverage with an “Overweight” rating.
28 January 2026
···
Bloom Energy stock pops after hours as Jefferies lifts target, earnings next up

Bloom Energy stock pops after hours as Jefferies lifts target, earnings next up

Bloom Energy shares jumped 9% to $152.31 in after-hours trading Tuesday after a volatile session with over 13 million shares traded. Jefferies raised its price target to $92 but kept an Underperform rating, citing new orders but warning on high valuation. Investors await Bloom’s Feb. 5 results for updates on capacity and deployment schedules.
28 January 2026
·····
RTX stock jumps after earnings beat, 2026 outlook; tariffs and defense orders in focus

RTX stock jumps after earnings beat, 2026 outlook; tariffs and defense orders in focus

RTX shares rose 3.7% to $201.28 in after-hours trading Tuesday after the company posted a 12% jump in fourth-quarter sales to $24.2 billion and issued a 2026 outlook above some forecasts. Jet-engine demand and aircraft repairs drove growth, while defense spending stayed steady. RTX projected 2026 adjusted sales of $92–93 billion and free cash flow of $8.25–8.75 billion. Investors are watching tariffs and new defense policy changes.
28 January 2026
···
GM stock price jumps nearly 9% after earnings, new outlook; what traders watch next

GM stock price jumps nearly 9% after earnings, new outlook; what traders watch next

GM shares jumped 8.8% to $86.38 in after-hours trading Tuesday after the company raised its 2026 profit outlook and announced a $6 billion buyback. Fourth-quarter adjusted pre-tax earnings rose 13% to $2.84 billion, but a $6 billion EV charge led to a $3.3 billion loss. GM boosted its dividend 20% to $0.18 per share. Investors are watching for sustained momentum and the pace of buybacks.
28 January 2026
··
1 … 43 44 45 46 47 … 203

Stock Market Today

KLA stock price jumps 8% as chip rebound lifts KLAC — what to know before Monday

KLA stock price jumps 8% as chip rebound lifts KLAC — what to know before Monday

8 February 2026
KLA Corp shares surged 8.4% to $1,442.95 Friday, leading gains in chip-equipment stocks after Amazon announced a major increase in capital spending. About 1.6 million KLA shares traded as the PHLX semiconductor index rose 5.7%. KLA’s board declared a $1.90 quarterly dividend, payable March 3 to holders as of Feb. 17. Applied Materials and Lam Research also rallied sharply into the close.
Go toTop